IRIS UniCatt

Avolio, Alfonso Wolfango
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.323
EU - Europa 5.094
AS - Asia 4.242
SA - Sud America 976
AF - Africa 103
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
Totale 15.761
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.170
SG - Singapore 1.893
DE - Germania 1.548
CN - Cina 1.354
SE - Svezia 902
BR - Brasile 816
IT - Italia 589
UA - Ucraina 536
FR - Francia 326
GB - Regno Unito 278
IE - Irlanda 263
VN - Vietnam 216
PL - Polonia 176
FI - Finlandia 173
ID - Indonesia 157
IN - India 118
TR - Turchia 89
RU - Federazione Russa 87
CA - Canada 85
BD - Bangladesh 66
HK - Hong Kong 64
AR - Argentina 63
MX - Messico 46
BE - Belgio 43
IQ - Iraq 43
JP - Giappone 43
KR - Corea 40
ZA - Sudafrica 38
ES - Italia 30
IR - Iran 29
AT - Austria 25
EC - Ecuador 24
VE - Venezuela 24
LT - Lituania 22
NL - Olanda 21
PK - Pakistan 19
SA - Arabia Saudita 18
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 14
MA - Marocco 14
RO - Romania 14
CH - Svizzera 13
CL - Cile 13
CO - Colombia 13
KE - Kenya 12
EG - Egitto 10
EU - Europa 10
CZ - Repubblica Ceca 9
AU - Australia 8
AZ - Azerbaigian 7
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
PY - Paraguay 7
UY - Uruguay 7
BY - Bielorussia 6
JO - Giordania 6
NP - Nepal 6
PE - Perù 6
BG - Bulgaria 5
KZ - Kazakistan 5
PA - Panama 5
PH - Filippine 5
TN - Tunisia 5
DK - Danimarca 4
EE - Estonia 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
AO - Angola 3
BH - Bahrain 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
MD - Moldavia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
BO - Bolivia 2
BW - Botswana 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
GA - Gabon 2
GE - Georgia 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
MU - Mauritius 2
OM - Oman 2
QA - Qatar 2
TW - Taiwan 2
AL - Albania 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
Totale 15.750
Salva come PNG Salva come JPEG
Città #
Chandler 770
Singapore 755
Ashburn 600
Jacksonville 289
Beijing 272
Dublin 256
San Mateo 235
Ann Arbor 177
Munich 165
Nanjing 155
Rome 148
Jakarta 142
New York 129
Wilmington 120
Boston 119
Los Angeles 116
Warsaw 111
Hefei 102
Marseille 96
The Dalles 94
Milan 93
Woodbridge 90
Seattle 84
Mcallen 83
Lawrence 82
Dearborn 77
Houston 77
Nürnberg 72
Bremen 68
Ho Chi Minh City 68
Redwood City 68
Fairfield 64
Frankfurt am Main 63
Nanchang 61
Izmir 60
Hanoi 58
Chicago 57
Hong Kong 56
São Paulo 56
Moscow 54
Shenyang 54
Dallas 53
Cattolica 49
Princeton 47
Hangzhou 46
Helsinki 43
Hebei 42
University Park 41
Buffalo 40
Zhengzhou 40
Brussels 39
Tianjin 37
Lancaster 36
Andover 33
Santa Clara 31
Kraków 30
London 28
Mountain View 28
Augusta 27
Johannesburg 27
Kunming 27
Nuremberg 27
Shanghai 27
Tokyo 27
Changsha 26
Turku 26
Guangzhou 25
Rio de Janeiro 25
Montréal 24
Seoul 23
Belo Horizonte 22
Kent 22
Norwalk 22
Pune 22
Atlanta 21
Baghdad 21
Toronto 21
Brooklyn 20
Chengdu 20
Dhaka 20
Jiaxing 19
Ningbo 18
Curitiba 17
Fremont 17
Hounslow 17
Kish 17
Detroit 16
Phoenix 16
Cambridge 15
Boardman 14
Brasília 14
Denver 13
Guarulhos 13
Porto Alegre 13
Stockholm 13
Jinan 12
Vienna 12
Goiânia 11
Guayaquil 11
Montreal 11
Totale 7.770
Salva come PNG Salva come JPEG
Nome #
Low values of left ventricular ejection time in the post-anhepatic phase may be associated with occurrence of primary graft dysfunction after orthotopic liver transplantation: results of a single-centre case-control study 391
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 334
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 291
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 205
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 199
Duplex Doppler in the postoperative monitoring of liver transplant recipients 192
Prediction of poor graft function by means of gastric tonometry in patients undergoing liver transplantation 185
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 182
Accidental transplantation of a kidney with stones: case report 178
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 172
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 172
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 170
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 157
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 155
Liver transplantation in patients with alcoholic liver disease: A retrospective study 154
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 154
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 151
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 149
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 149
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 145
Lack of predictivity of serum neopterin, soluble interleukin-2 receptor, and serum amyloid A in long-term kidney transplant recipients 144
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 144
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 143
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 141
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 138
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 137
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 135
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 135
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 134
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 134
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 133
Prediction of 6-month survival after liver transplantation using Cox regression. 132
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 131
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 130
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 129
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 129
Model for end-stage liver disease dynamic stratification of survival benefit 129
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 129
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 127
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 127
A Bayesan methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. 125
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 124
Is primary nonfunction still a suitable indication for liver retransplantation? 124
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 123
Psychological risk factors for graft rejection among liver transplant recipients 121
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 119
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 118
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 118
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 117
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 115
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 114
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 113
Viscoelastic versus conventional coagulation tests to reduce blood product transfusion in patients undergoing liver transplantation: A systematic review and meta-analysis 112
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 112
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 112
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 112
L-GrAFT and EASE scores in liver transplantation. Need for a reciprocal external validation and comparison with other scores 112
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 111
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 108
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 108
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 107
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 106
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 106
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 106
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 105
High-Flow Nasal Cannula Versus Standard Oxygen Therapy After Extubation in Liver Transplantation: A Matched Controlled Study 105
Pediatric T-tube in adult liver transplantation: Technical refinements of insertion and removal 105
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 103
Use of O blood group liver donors for nonidentical recipients: does this represent a double penalty for O blood group candidates? 103
CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study 103
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 101
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 100
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 100
Should retransplantation still be considered for primary non-function after liver transplantation? 98
Celiac axis compression syndrome in liver transplantation 98
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 97
Primary difunction after liver trasplantation: donor or recipients fault? 97
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation 97
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 97
Quantification of liver damage and prediction of 1-year survival after liver transplantation by a multifactorial "recovery score" 96
Availability of a Web and Smartphone Application to Stratify the Risk of of Early Allograft Failure Requiring Liver Retransplantation 95
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. 95
Clinical problems of the transplanted kidney 95
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 95
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 95
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 94
Development and validation of a comprehensive model to predict complications after hepatectomy 93
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 92
Toward a novel evidence-based definition of early allograft failure in the perspective of liver retransplant. 92
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 91
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 90
Hepatitis B-core Antibody Positive Donors in Liver Transplantation and Their Impact on Graft Survival: Evidence From The Liver Match Cohort Study 89
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 89
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 88
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation 88
ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption 87
Balancing Donor and Recipient Risk Factors in Liver Transplantation: The Value of D-MELD With Particular Reference to HCV Recipients 85
Liver transplantation for fulminant liver failure: a dilemma in therapeutic approach 85
Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios 84
Cefotetan versus cefoxitin in peritonitis 84
Totale 12.720
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.706
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021621 0 0 0 0 0 50 114 19 132 71 212 23
2021/20221.377 85 188 32 108 66 52 11 226 60 56 220 273
2022/20232.323 279 300 219 346 139 291 132 185 252 55 100 25
2023/20241.184 48 378 25 159 54 118 82 38 15 54 106 107
2024/20252.573 45 61 199 95 202 113 66 97 414 282 568 431
2025/20263.650 1.008 204 404 768 1.025 241 0 0 0 0 0 0
Totale 15.889